Iovance Biotherapeutics, Inc.

DB:2LB Stock Report

Market Cap: €2.4b

Iovance Biotherapeutics, Inc. Company Information

Iovance Biotherapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Iovance Biotherapeutics, Inc.
  • Ticker: 2LB
  • Exchange: DB
  • Founded: 2007
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$2.511b
  • Listing Market Cap: US$2.400b
  • Shares Outstanding: 304.78m
  • Website: https://www.iovance.com

Number of Employees

Location

  • Iovance Biotherapeutics, Inc.
  • 825 Industrial Road
  • Suite 400
  • San Carlos
  • California
  • 94070
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IOVANasdaqGM (Nasdaq Global Market)YesCommon SharesUSUSDJun 2008
2LBDB (Deutsche Boerse AG)YesCommon SharesDEEURJun 2008
0JDKLSE (London Stock Exchange)YesCommon SharesGBUSDJun 2008

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/22 18:22
End of Day Share Price 2024/11/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.